NCT07021066
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07021066
Title Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SystImmune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85266 United States Details
Valkyrie Clinical Trials Los Angeles California 90067 United States Details
University of Colorado Health Aurora Colorado 80045 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Ochsner Medical Center New Orleans Louisiana 70121 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Sarah Cannon Research Institute - Oncology Partners Nashville Tennessee 37203 United States Details
NEXT Oncology- Austin Austin Texas 78758 United States Details
NEXT Oncology- Dallas Dallas Texas 75039 United States Details
NEXT Oncology San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field